Anders Morten Grejs

Anders Morten Grejs

Auto-generated profile, based on publicly available information

Anders Morten Grejs

Department of Intensive Care Medicine Aarhus University Hospital Aarhus Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2017 in JAMA
Verified
Journal Article
Open access
PDF file
HKHans Kirkegaard
Hans Kirkegaard
ESEldar Søreide
Eldar Søreide
IHInge de Haas
Inge de Haas
VPVille Pettilä
Ville Pettilä
FTFabio Silvio Taccone
Fabio Silvio Taccone
MSMarkus B. Skrifvars
Markus B. Skrifvars
Short- and long-term outcomes in unconscious patients admitted to the intensive care unit (ICU) after out-of-hospital cardiac arrest are characterized by prognostic uncertainty and a high risk of death and neurologic deficit.1 To improve the chance of survival and neurologic recovery, international guidelines recommend use of targeted temperature management (TTM), together with urgent coronary angiography and percutaneous coronary intervention when appropriate, and delayed multimodal prognostication before withdrawal of care.2

1 January 2018 in Resuscitation
Verified
Journal Article
Closed access
CDChristophe Henri Valdemar Duez
Christophe Henri Valdemar Duez
AGAnders Morten Grejs
Anders Morten Grejs
AJAnni Nørgaard Jeppesen
Anni Nørgaard Jeppesen
ASAnne Dilani Schrøder
Anne Dilani Schrøder
ESEldar Søreide
Eldar Søreide
HKHans Kirkegaard
Hans Kirkegaard

1 February 2019 in Resuscitation
Verified
Journal Article
Closed access
CDChristophe Henri Valdemar Duez
Christophe Henri Valdemar Duez
BJBirger Johnsen
Birger Johnsen
MEMads Qvist Ebbesen
Mads Qvist Ebbesen
MKMarie Bu Kvaløy
Marie Bu Kvaløy
AGAnders Morten Grejs
Anders Morten Grejs
HKHans Kirkegaard
Hans Kirkegaard

4 May 2016 in Trials
Verified
Journal Article
Open access
PDF file
HKHans Kirkegaard
Hans Kirkegaard
BRBodil S Rasmussen
Bodil S Rasmussen
IHInge de Haas
Inge de Haas
JNJørgen Feldbæk Nielsen
Jørgen Feldbæk Nielsen
SISusanne Ilkjær
Susanne Ilkjær
ESEldar Søreide
Eldar Søreide
The application of therapeutic hypothermia (TH) for 12 to 24 hours following out-of-hospital cardiac arrest (OHCA) has been associated with decreased mortality and improved neurological function. However, the optimal duration of cooling is not known. We aimed to investigate whether targeted temperature management (TTM) at 33 ± 1 °C for 48 hours compared to 24 hours results in a better long-term neurological outcome. The TTH48 trial is an investigator-initiated pragmatic international trial in which patients resuscitated from OHCA are randomised to TTM at 33 ± 1 °C for either 24 or 48 hours. Inclusion criteria are: age older than 17 and below 80 years; presumed cardiac origin of arrest; and Glasgow Coma Score (GCS) <8, on admission. The primary outcome is neurological outcome at 6 months using the Cerebral Performance Category score (CPC) by an assessor blinded to treatment allocation and dichotomised to good (CPC 1–2) or poor (CPC 3–5) outcome. Secondary outcomes are: 6-month mortality, incidence of infection, bleeding and organ failure and CPC at hospital discharge, at day 28 and at day 90 following OHCA. Assuming that 50 % of the patients treated for 24 hours will have a poor outcome at 6 months, a study including 350 patients (175/arm) will have 80 % power (with a significance level of 5 %) to detect an absolute 15 % difference in primary outcome between treatment groups. A safety interim analysis was performed after the inclusion of 175 patients. This is the first randomised trial to investigate the effect of the duration of TTM at 33 ± 1 °C in adult OHCA patients. We anticipate that the results of this trial will add significant knowledge regarding the management of cooling procedures in OHCA patients. NCT01689077

22 February 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
CFChiara De Fazio
Chiara De Fazio
MSMarkus Skrifvars
Markus Skrifvars
ESEldar Søreide
Eldar Søreide
JCJacques Creteur
Jacques Creteur
AGAnders M. Grejs
Anders M. Grejs
Fabio Silvio TacconeFabio Silvio Taccone
Fabio Silvio Taccone
The aim of this study was to explore the performance and outcomes for intravascular (IC) versus surface cooling devices (SFC) for targeted temperature management (TTM) after out-of-hospital cardiac arrest. A retrospective analysis of data from the Time-differentiated Therapeutic Hypothermia (TTH48) trial (NCT01689077), which compared whether TTM at 33 °C for 48 h results in better neurologic outcomes compared with standard 24-h duration. Devices were assessed for the speed of cooling and rewarming rates. Precision was assessed by measuring temperature variability (TV), i.e., the standard deviation (SD) of all temperature measurements in the cooling phase. Main outcomes were overall mortality and poor neurological outcome, including death, severe disability, or vegetative status. A total of 352 patients had available data and were included in the analysis; of those, 218 (62%) were managed with IC. A total of 114/218 (53%) patients with IC and 61/134 (43%) with SFC were cooled for 48 h (p = 0.22). Time to target temperature (≤ 34 °C) was significantly shorter for patients treated with endovascular devices (2.2 [1.1–4.0] vs. 4.2 [2.7–6.0] h, p < 0.001), but temperature was also lower on admission (35.0 [34.2–35.6] vs. 35.3 [34.5–35.8]°C; p = 0.02) and cooling rate was similar (0.4 [0.2–0.8] vs. 0.4 [0.2–0.6]°C/h; p = 0.14) when compared to SFC. Temperature variability was significantly lower in the endovascular device group when compared with SFC methods (0.6 [0.4–0.9] vs. 0.7 [0.5–1.0]°C; p = 0.007), as was rewarming rate (0.31 [0.22–0.44] vs. 0.37 [0.29–0.49]°C/hour; p = 0.02). There was no statistically significant difference in mortality (endovascular 65/218, 29% vs. others 43/134, 32%; p = 0.72) or poor neurological outcome (endovascular 69/218, 32% vs. others 51/134, 38%; p = 0.24) between type of devices. Endovascular cooling devices were more precise than SFC methods in patients cooled at 33 °C after out-of-hospital cardiac arrest. Main outcomes were similar with regard to the cooling methods.

1 January 2019 in Resuscitation
Verified
Journal Article
Closed access
LELars Evald
Lars Evald
KBKolbjørn Brønnick
Kolbjørn Brønnick
CDChristophe Henri Valdemar Duez
Christophe Henri Valdemar Duez
AGAnders Morten Grejs
Anders Morten Grejs
AJAnni Nørgaard Jeppesen
Anni Nørgaard Jeppesen
JNJørgen Feldbæk Nielsen
Jørgen Feldbæk Nielsen